These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 34712855)

  • 1. Perfluoroalkyl substances exposure and immunity, allergic response, infection, and asthma in children: review of epidemiologic studies.
    von Holst H; Nayak P; Dembek Z; Buehler S; Echeverria D; Fallacara D; John L
    Heliyon; 2021 Oct; 7(10):e08160. PubMed ID: 34712855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood.
    Granum B; Haug LS; Namork E; Stølevik SB; Thomsen C; Aaberge IS; van Loveren H; Løvik M; Nygaard UC
    J Immunotoxicol; 2013; 10(4):373-9. PubMed ID: 23350954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between perfluoroalkyl substance exposure and asthma and allergic disease in children as modified by MMR vaccination.
    Timmermann CA; Budtz-Jørgensen E; Jensen TK; Osuna CE; Petersen MS; Steuerwald U; Nielsen F; Poulsen LK; Weihe P; Grandjean P
    J Immunotoxicol; 2017 Dec; 14(1):39-49. PubMed ID: 28091126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal levels of perfluoroalkyl substances (PFASs) during pregnancy and childhood allergy and asthma related outcomes and infections in the Norwegian Mother and Child (MoBa) cohort.
    Impinen A; Longnecker MP; Nygaard UC; London SJ; Ferguson KK; Haug LS; Granum B
    Environ Int; 2019 Mar; 124():462-472. PubMed ID: 30684804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perfluoroalkyl substances, airways infections, allergy and asthma related health outcomes - implications of gender, exposure period and study design.
    Kvalem HE; Nygaard UC; Lødrup Carlsen KC; Carlsen KH; Haug LS; Granum B
    Environ Int; 2020 Jan; 134():105259. PubMed ID: 31733527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal exposure to perfluoralkyl substances (PFASs) associated with respiratory tract infections but not allergy- and asthma-related health outcomes in childhood.
    Impinen A; Nygaard UC; Lødrup Carlsen KC; Mowinckel P; Carlsen KH; Haug LS; Granum B
    Environ Res; 2018 Jan; 160():518-523. PubMed ID: 29106950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prenatal exposure to per- and polyfluoroalkyl substances on childhood allergies and common infectious diseases in children up to age 7 years: The Hokkaido study on environment and children's health.
    Ait Bamai Y; Goudarzi H; Araki A; Okada E; Kashino I; Miyashita C; Kishi R
    Environ Int; 2020 Oct; 143():105979. PubMed ID: 32717646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD).
    Pfaar O; Bachert C; Bufe A; Buhl R; Ebner C; Eng P; Friedrichs F; Fuchs T; Hamelmann E; Hartwig-Bade D; Hering T; Huttegger I; Jung K; Klimek L; Kopp MV; Merk H; Rabe U; Saloga J; Schmid-Grendelmeier P; Schuster A; Schwerk N; Sitter H; Umpfenbach U; Wedi B; Wöhrl S; Worm M; Kleine-Tebbe J; Kaul S; Schwalfenberg A
    Allergo J Int; 2014; 23(8):282-319. PubMed ID: 26120539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human exposure pathways to poly- and perfluoroalkyl substances (PFAS) from indoor media: A systematic review protocol.
    DeLuca NM; Angrish M; Wilkins A; Thayer K; Cohen Hubal EA
    Environ Int; 2021 Jan; 146():106308. PubMed ID: 33395950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.
    Callaghan A; Kendall G; Lock C; Mahony A; Payne J; Verrier L
    JBI Libr Syst Rev; 2005; 3(6):1-33. PubMed ID: 27819973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cord blood gene expression supports that prenatal exposure to perfluoroalkyl substances causes depressed immune functionality in early childhood.
    Pennings JL; Jennen DG; Nygaard UC; Namork E; Haug LS; van Loveren H; Granum B
    J Immunotoxicol; 2016; 13(2):173-80. PubMed ID: 25812627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to Perfluorinated Alkyl Substances and Health Outcomes in Children: A Systematic Review of the Epidemiologic Literature.
    Rappazzo KM; Coffman E; Hines EP
    Int J Environ Res Public Health; 2017 Jun; 14(7):. PubMed ID: 28654008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal perfluorooctanoic acid exposure is associated with early onset atopic dermatitis in 5-year-old children.
    Wen HJ; Wang SL; Chuang YC; Chen PC; Guo YL
    Chemosphere; 2019 Sep; 231():25-31. PubMed ID: 31128349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
    Halken S
    Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PFAS (per- and polyfluoroalkyl substances) and asthma in young children: NHANES 2013-2014.
    Jackson-Browne MS; Eliot M; Patti M; Spanier AJ; Braun JM
    Int J Hyg Environ Health; 2020 Aug; 229():113565. PubMed ID: 32485600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internal exposure to perfluoroalkyl substances (PFASs) and biological markers in 101 healthy 1-year-old children: associations between levels of perfluorooctanoic acid (PFOA) and vaccine response.
    Abraham K; Mielke H; Fromme H; Völkel W; Menzel J; Peiser M; Zepp F; Willich SN; Weikert C
    Arch Toxicol; 2020 Jun; 94(6):2131-2147. PubMed ID: 32227269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimated exposures to perfluorinated compounds in infancy predict attenuated vaccine antibody concentrations at age 5-years.
    Grandjean P; Heilmann C; Weihe P; Nielsen F; Mogensen UB; Timmermann A; Budtz-Jørgensen E
    J Immunotoxicol; 2017 Dec; 14(1):188-195. PubMed ID: 28805477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal exposure to perfluoroalkyl substances, immune-related outcomes, and lung function in children from a Spanish birth cohort study.
    Manzano-Salgado CB; Granum B; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Gascón M; Martínez D; Guxens M; Basterretxea M; Zabaleta C; Schettgen T; Sunyer J; Vrijheid M; Casas M
    Int J Hyg Environ Health; 2019 Jul; 222(6):945-954. PubMed ID: 31262703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Perfluoroalkyl Substances, Vaccine Responses, and Morbidity in a Cohort of Guinea-Bissau Children.
    Timmermann CAG; Jensen KJ; Nielsen F; Budtz-Jørgensen E; van der Klis F; Benn CS; Grandjean P; Fisker AB
    Environ Health Perspect; 2020 Aug; 128(8):87002. PubMed ID: 32772733
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.